Functional proteomic analysis of GS‐NS0 murine myeloma cell lines with varying recombinant monoclonal antibody production rate
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
We previously compared changes in individual protein abundance between the proteomes of GS‐NS0 cell lines with varying rates of cell‐specific recombinant monoclonal antibody production (qMab). Here we extend analyses of our proteomic dataset to statistically determine if particular cell lines have distinct functional capabilities that facilitate production of secreted recombinant Mab. We categorized 79 proteins identified by mass spectrometry according to their biological function or location in the cell and statistically compared the relative abundance of proteins in each category between GS‐NS0 cell lines with varying qMab. We found that the relative abundance of proteins in ER chaperone, non‐ER chaperone, cytoskeletal, cell signaling, metabolic, and mitochondrial categories were significantly increased with qMab. As the GS‐NS0 cell line with highest qMab also had an increased intracellular abundance of unassembled Mab heavy chain (HC), we tested the hypothesis that the increased ER chaperone content was caused by induction of an unfolded protein response (UPR) signaling pathway. Immunoblot analyses revealed that spliced X‐box binding protein 1 (XBP1), a marker for UPR induction, was not detectable in the GS‐NS0 cells with elevated qMab, although it was induced by chemical inhibitors of protein folding. These data suggest that qMab is functionally related to the abundance of specific categories of proteins that together facilitate recombinant protein production. We infer that individual cells within parental populations are more functionally equipped for high‐level recombinant protein production than others and that this bias could be used to select cells that are more likely to achieve high qMab. © 2006 Wiley Periodicals, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
limma: Linear Models for Microarray Data
Smyth, G. K. (2005) · Statistics for Biology and Health · doi:10.1007/0-387-29362-0_23 · Cited by 5,796
Escherichia coli K-12 undergoes adaptive evolution to achieve in silico predicted optimal growth
Ibarra, R. U., Edwards, J. S., & Palsson, B. O. (2002) · Nature · doi:10.1038/nature01149 · Cited by 857
Sriburi, R., Jackowski, S., Mori, K., & Brewer, J. W. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200406136 · Cited by 653
Smales, C. M., Dinnis, D. M., Stansfield, S. H., Alete, D., Sage, E. A., Birch, J. R., Racher, A. J., Marshall, C. T., & James, D. C. (2004) · Biotechnology and Bioengineering · doi:10.1002/bit.20272 · Cited by 119
Self-citationImpact of ‘ome’ analyses on inverse metabolic engineering
Bro, C., & Nielsen, J. (2004) · Metabolic Engineering · doi:10.1016/j.ymben.2003.11.005 · Cited by 116
Relationship between cell size, cell cycle and specific recombinant protein productivity
Lloyd, D. R., Holmes, P., Jackson, L. P., Emery, A. N., & Al-Rubeai, M. (2000) · Cytotechnology · doi:10.1023/a:1008103730027 · Cited by 93 · cited 2×
“Previous studies have suggested that cell size is a major determinant of recombinant protein productivity (Lloyd et al., 2000).”
Background
Cited by
Dietmair, S., Timmins, N. E., Gray, P. P., Nielsen, L. K., & Krömer, J. O. (2010) · Analytical Biochemistry · doi:10.1016/j.ab.2010.04.031 · Cited by 322
Self-citationTherapeutic glycoprotein production in mammalian cells
Lalonde, M.-E., & Durocher, Y. (2017) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2017.04.028 · Cited by 296
Guidelines to cell engineering for monoclonal antibody production
Rita Costa, A., Elisa Rodrigues, M., Henriques, M., Azeredo, J., & Oliveira, R. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2009.10.002 · Cited by 178
“To ease the passage from adherent to suspension culture, two approaches can be followed: media optimization (for example, altering cation concentration) [192] and the use of specially treated glass and plasticware [4].”
BackgroundMethodFeichtinger, J., Hernández, I., Fischer, C., Hanscho, M., Auer, N., Hackl, M., Jadhav, V., Baumann, M., Krempl, P. M., Schmidl, C., et al. (2016) · Biotechnology and Bioengineering · doi:10.1002/bit.25990 · Cited by 148
“, 2013), while most of the available literature compares gene expression patterns in different CHO clones that produce recombinant protein(s), trying to capture the differences that define their performance in industrial processes, with a focus on high productivity and growth (Charaniya et al., 2009; Clarke et al., 20…”
BackgroundOhya, T., Hayashi, T., Kiyama, E., Nishii, H., Miki, H., Kobayashi, K., Honda, K., Omasa, T., & Ohtake, H. (2008) · Biotechnology and Bioengineering · doi:10.1002/bit.21758 · Cited by 96
Ghorbaniaghdam, A., Chen, J., Henry, O., & Jolicoeur, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090832 · Cited by 71
Detailed understanding of enhanced specific antibody productivity in NS0 myeloma cells
Khoo, S. H. G., & Al‐Rubeai, M. (2009) · Biotechnology and Bioengineering · doi:10.1002/bit.22041 · Cited by 38
“Dinnis et al. (2006) analysed four different clones with varying specific productivities and suggested that a denser cell, that is one having a high protein to cell volume ratio, would give a higher specific productivity.”
Background
Metadata
- Authors
- Dinnis, D. M., Stansfield, S. H., Schlatter, S., Smales, C. M., Alete, D., Birch, J. R., Racher, A. J., Marshall, C. T., Nielsen, L. K., & James, D. C.
- Venue
- Biotechnology and Bioengineering
- Publisher
- Wiley
- Published
- 2006-06-28
- Volume
- 94
- Issue
- 5
- Pages
- 830-841
- ISSN
- 0006-3592 (ISSN-L)
- 1097-0290
- OpenAlex
- W2075414171
- Cited by
- 139
- References
- 6
- FWCI
- 6.51
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.